The Department of Sports and Recreation has continued to show its support for Caster Semenya.Semenya is in a ongoing court battle with the Court of Arbitration for Sport.Semenya won gold at the Rio Olympics in 2016 in the 800m event.The Department of Sports and Recreation will continue to fight for reigning Olympic champion Caster Semenya following…
Caster Semenya (Getty Images) South African Olympic champion Caster Semenya has locked her focus into the 200m, no matter the result of her appeal to overturn last year's Court of Arbitration for Sport (CAS) decision.Before the Covid-19 pandemic rocked the sporting globe, Semenya was in a court battle to get the CAS decision that allowed…
South African Olympic 200m sprinter Anaso Jobodwana says the Covid-19 pandemic that's caused the postponement of the 2020 Tokyo Games to next year could gift track team-mate Caster Semenya valuable time to fight her case against the International Association of Athletics Federations (IAAF).Semenya lost her case against the IAAF at the Swiss-based Court of Arbitration…
Robert F. Kennedy Jr. has rightly made “radical transparency” the motto of his Department of Health and Human Services. HHS even has a page by that name. I think it is a good motto, and I want to help Secretary Kennedy and Acting FDA Commissioner Kyle Diamantas deliver on it in food safety, with two citizen petitions
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment